Gene · 6241
Papers4,414
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 4,414
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterization of a ferroptosis-related gene signature predicting survival and immunotherapeutic response in lung adenocarcinoma. | Aging (Albany NY) | 2024 | 39311766 | PubTator, text mining | PubMed |
| Circular RNA RRM2 alleviates metabolic dysfunction-associated steatotic liver disease by targeting miR-142-5p to increase NRG1 expression. | Am J Physiol Gastrointest Liver Physiol | 2024 | 39259911 | PubTator, text mining | PubMed |
| Ferroptosis-related genes DUOX1 and HSD17B11 affect tumor microenvironment and predict overall survival of lung adenocarcinoma patients. | Medicine (Baltimore) | 2024 | 39259123 | PubTator, text mining | PubMed |
| HBx promotes tumorigenicity through RRM2-mediated autophagy in hepatocellular carcinoma. | Cell Biosci | 2024 | 39256879 | PubTator, text mining | PubMed |
| Prognostic significance of a 3-gene ferroptosis-related signature in lung cancer via LASSO analysis and cellular functions of UBE2Z. | Comput Biol Chem | 2024 | 39243550 | PubTator, text mining | PubMed |
| Membrane RRM2-positive cells represent a malignant population with cancer stem cell features in intrahepatic cholangiocarcinoma. | J Exp Clin Cancer Res | 2024 | 39243109 | PubTator, text mining | PubMed |
| On discovery of novel hub genes for ER+ and TN breast cancer types through RNA seq data analyses and classification models. | Sci Rep | 2024 | 39242688 | PubTator, text mining | PubMed |
| Esophageal chemical burns as a risk factor for esophageal malignancies: in-silico analyses - experimental research. | Ann Med Surg (Lond) | 2024 | 39239040 | PubTator, text mining | PubMed |
| Identification and Mendelian randomization validation of pathogenic gene biomarkers in obstructive sleep apnea. | Front Neurol | 2024 | 39220737 | PubTator, text mining | PubMed |
| The prognostic and clinical value of genes associate with immunity and amino acid Metabolism in Lung Adenocarcinoma. | Heliyon | 2024 | 39183890 | PubTator, text mining | PubMed |
| miR-185-5p rewires cisplatin resistance by restoring miR-203a-3p expression via downregulation of SOX9. | DNA Repair (Amst) | 2024 | 39173500 | PubTator, text mining | PubMed |
| Ferroptosis-Related Genes in IgA Nephropathy: Screening for Potential Targets of the Mechanism. | Int J Genomics | 2024 | 39171207 | PubTator, text mining | PubMed |
| RNA interference targeting WSSV ribonucleotide reductase 2 provides long-term protection against infection in Litopenaeus vannamei. | Dis Aquat Organ | 2024 | 39145473 | PubTator, text mining | PubMed |
| Structural basis for RNA recognition by the C-terminal RRM domain of human RBM45. | J Biol Chem | 2024 | 39122006 | PubTator, text mining | PubMed |
| Deciphering the Molecular Complexity of Hepatocellular Carcinoma: Unveiling Novel Biomarkers and Therapeutic Targets Through Advanced Bioinformatics Analysis. | Cancer Rep (Hoboken) | 2024 | 39118438 | PubTator, text mining | PubMed |
| [Identification of key genes and functions in lung metastasis of osteosarcoma based on bioinformatics]. | Zhongguo Gu Shang | 2024 | 39104075 | PubTator, text mining | PubMed |
| Corrigendum to: lncRNA CYTOR promotes lung adenocarcinoma gemcitabine resistance and epithelial-mesenchymal transition by sponging miR-125a-5p and upregulating ANLN and RRM2. | Acta Biochim Biophys Sin (Shanghai) | 2024 | 39099412 | PubTator, text mining | PubMed |
| Ruthenium Drug BOLD-100 Regulates BRAFMT Colorectal Cancer Cell Apoptosis through AhR/ROS/ATR Signaling Axis Modulation. | Mol Cancer Res | 2024 | 39083088 | PubTator, text mining | PubMed |
| Identification of the ferroptosis-related gene signature and the associated regulation axis in lung cancer and rheumatoid arthritis. | Genes Immun | 2024 | 39080453 | PubTator, text mining | PubMed |
| Combined inhibition of EZH2 and CDK4/6 perturbs endoplasmic reticulum-mitochondrial homeostasis and increases antitumor activity against glioblastoma. | NPJ Precis Oncol | 2024 | 39054369 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6241/papers?page=14